- Home
- AGEN vs COE Comparison
AGEN vs COE Comparison
Compare AGEN & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- COE
- Stock Information
- Founded
- AGEN 1994
- COE 2011
- Country
- AGEN United States
- COE Singapore
- Employees
- AGEN N/A
- COE N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- COE Other Consumer Services
- Sector
- AGEN Health Care
- COE Real Estate
- Exchange
- AGEN Nasdaq
- COE Nasdaq
- Market Cap
- AGEN 96.2M
- COE 115.0M
- IPO Year
- AGEN 2000
- COE 2016
- Fundamental
- Price
- AGEN $3.32
- COE $19.78
- Analyst Decision
- AGEN Buy
- COE
- Analyst Count
- AGEN 3
- COE 0
- Target Price
- AGEN $10.50
- COE N/A
- AVG Volume (30 Days)
- AGEN 357.6K
- COE 19.1K
- Earning Date
- AGEN 03-13-2025
- COE 03-21-2025
- Dividend Yield
- AGEN N/A
- COE N/A
- EPS Growth
- AGEN N/A
- COE N/A
- EPS
- AGEN N/A
- COE N/A
- Revenue
- AGEN $160,427,000.00
- COE $41,924,000.00
- Revenue This Year
- AGEN N/A
- COE N/A
- Revenue Next Year
- AGEN $26.02
- COE N/A
- P/E Ratio
- AGEN N/A
- COE N/A
- Revenue Growth
- AGEN 59.00
- COE 69.79
- 52 Week Low
- AGEN $2.50
- COE $6.00
- 52 Week High
- AGEN $19.69
- COE $25.70
- Technical
- Relative Strength Index (RSI)
- AGEN 45.96
- COE 45.81
- Support Level
- AGEN $3.09
- COE $19.55
- Resistance Level
- AGEN $3.68
- COE $25.70
- Average True Range (ATR)
- AGEN 0.25
- COE 1.57
- MACD
- AGEN -0.03
- COE -0.34
- Stochastic Oscillator
- AGEN 23.00
- COE 8.36
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand.